U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
firivumab [INN]
Preferred Name English
FIRIVUMAB
INN   WHO-DD  
INN  
Official Name English
Firivumab [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(INFLUENZA A VIRUS HEMAGGLUTININ HA), HOMO SAPIENS MONOCLONAL ANTIBODY
Common Name English
Code System Code Type Description
SMS_ID
300000021892
Created by admin on Mon Mar 31 22:59:51 GMT 2025 , Edited by admin on Mon Mar 31 22:59:51 GMT 2025
PRIMARY
INN
9975
Created by admin on Mon Mar 31 22:59:51 GMT 2025 , Edited by admin on Mon Mar 31 22:59:51 GMT 2025
PRIMARY
FDA UNII
JC5C9983X2
Created by admin on Mon Mar 31 22:59:51 GMT 2025 , Edited by admin on Mon Mar 31 22:59:51 GMT 2025
PRIMARY
NCI_THESAURUS
C169982
Created by admin on Mon Mar 31 22:59:51 GMT 2025 , Edited by admin on Mon Mar 31 22:59:51 GMT 2025
PRIMARY
CAS
1443004-15-6
Created by admin on Mon Mar 31 22:59:51 GMT 2025 , Edited by admin on Mon Mar 31 22:59:51 GMT 2025
PRIMARY
ACTIVE MOIETY
FIRIVUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966